| Absorption |
| Blood-Brain Barrier | BBB- | 0.6476 |
| Human Intestinal Absorption | HIA+ | 0.8615 |
| Caco-2 Permeability | Caco2- | 0.6669 |
| P-glycoprotein Substrate | Substrate | 0.5399 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.5607 |
| Non-inhibitor | 0.9620 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9123 |
| Distribution |
| Subcellular localization | Mitochondria | 0.5567 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7521 |
| CYP450 2D6 Substrate | Non-substrate | 0.8022 |
| CYP450 3A4 Substrate | Substrate | 0.5242 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.7243 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.7677 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.8733 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.7571 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.8879 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8554 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9088 |
| Non-inhibitor | 0.6051 |
| AMES Toxicity | Non AMES toxic | 0.6312 |
| Carcinogens | Carcinogens | 0.6227 |
| Fish Toxicity | High FHMT | 0.9921 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9271 |
| Honey Bee Toxicity | High HBT | 0.5838 |
| Biodegradation | Not ready biodegradable | 0.9886 |
| Acute Oral Toxicity | III | 0.6104 |
| Carcinogenicity (Three-class) | Non-required | 0.6400 |